ASTM E2537

ASTM E2537 is the ASTM standard guide for applying continuous process verification to pharmaceutical and biopharmaceutical manufacturing. It provides a structured framework for understanding how ongoing monitoring and evaluation can support consistent process performance during routine production. As a technical document, it is relevant to manufacturers seeking a clearer approach to maintaining control, supporting quality objectives, and aligning process oversight with modern lifecycle expectations.

ASTM E2537 standard overview

The official title of ASTM E2537 indicates a guide focused on continuous process verification in pharmaceutical and biopharmaceutical manufacturing. In practical terms, it helps users think through how process data may be collected, reviewed, and used to confirm that a manufacturing process remains in a state of control. The standard is generally most useful as a reference for quality systems, process monitoring strategies, and compliance-oriented decision making within regulated manufacturing environments.

Where is ASTM E2537 used?

ASTM E2537 is commonly used in pharmaceutical and biopharmaceutical manufacturing settings where continuous verification approaches are part of process control strategy. It may be applied by organizations responsible for production, quality assurance, process development, and validation-related activities. The guide is relevant where manufacturers rely on ongoing data review to support process understanding, demonstrate consistency, and manage routine operations tied to drug or biologic production.

Practical importance of ASTM E2537

The practical value of ASTM E2537 lies in helping organizations apply a repeatable approach to continuous process verification. That can support stronger quality control, better consistency, and more defensible compliance practices. For procurement, engineering, and quality teams, it may serve as a useful reference when evaluating process monitoring expectations or internal procedures. Using the guide can also help reduce risk by encouraging structured oversight rather than relying only on end-point checks.

• Continuous process verification framework
• Pharmaceutical and biopharmaceutical manufacturing focus
• Process monitoring and review
• Quality control and compliance support
• Routine manufacturing consistency